The content on this site is intended for healthcare professionals only
Dr Ian Lewis speaks to ecancer.tv about a recent initiative where patients contribute to assessment of funding bids submitted to Tenovus.
Following a survey carried out in Tenovus stores across England and Wales asking what customers thought should be the priorities of Tenovus funding, a panel was set up consisting of patients, carers and other people who have been affected by cancer.
Dr Lewis discusses how the panel has successfully assessed clinical trial funding bids and explains how the project will be improved and expanded in the future.
Isatuximab plus lenalidomide and dexamethasone with bortezomib as a new standard of care for NDMM TI non-frail patients
Guiding transplant decisions in multiple myeloma with MRD
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
Advancements in paediatric Acute lymphoblastic leukemia management
Enhancing head and neck oncology: Key insights from the conference
Choosing the right patients for transplant
Understanding the use of PARPi combinations to treat patients with mCRPC
Durable responses in aRCC, how do we optimise treatment?
Pembrolizumab combined with xelox and bevacizumab shows higher efficacy than standard therapeutic regimen in mCRC
